Carpenter Christopher L.
Chief Medical Officer at Rubius Therapeutics, Inc.
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 16, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Rubius Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Rubius Therapeutics, Inc.UnusualMar 15 2019
Sold 48,000 shares at $15.84 ($760k)
Carpenter Christopher L., Chief Medical Officer
Sold 57.9% of holdings ($1.3M position)34,843 shares leftFirst sale on recordFiling
- 2 Form 4 sale Rubius Therapeutics, Inc.UnusualJun 19 +96 days
Sold 47,757 shares at $14.02 ($670k)
Carpenter Christopher L., Chief Medical Officer
Sold 57.8% of holdings ($1.2M position)34,843 shares leftFiling
- 3 Form 4 sale Rubius Therapeutics, Inc.Plan not statedJun 20 +1 day
Sold 243 shares at $13.93 ($3k)
Carpenter Christopher L., Chief Medical Officer
Sold 0.7% of holdings ($489k position)34,843 shares leftFiling
- 4 Form 4 sale Rubius Therapeutics, Inc.UnusualSep 17 +89 days
Sold 48,000 shares at $10.11 ($485k)
Carpenter Christopher L., Chief Medical Officer
Sold 57.9% of holdings ($838k position)34,843 shares left1x usual sizeFiling
- 5 Form 4 sale Rubius Therapeutics, Inc.UnusualDec 16 +90 days
Sold 48,000 shares at $13.48 ($647k)
Carpenter Christopher L., Chief Medical Officer
Sold 57.9% of holdings ($1.1M position)34,843 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2019 | Rubius Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 48,000 | $647k | 57.9% | Unusual | SEC |
| Sep 17, 2019 | Rubius Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 48,000 | $485k | 57.9% | Unusual | SEC |
| Jun 20, 2019 | Rubius Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 243 | $3k | 0.7% | Plan not stated | SEC |
| Jun 19, 2019 | Rubius Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 47,757 | $670k | 57.8% | Unusual | SEC |
| Mar 15, 2019 | Rubius Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 48,000 | $760k | 57.9% | Unusual | SEC |